BRIEF-AstraZeneca open to acquisitions, smaller deals more likely

* CEO says no comment on Pfizer, completely focused on developing pipeline
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.